-
- Enzo Bonora
- Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, Verona, Italy
-
- Stefan Kiechl
- Department of Neurology, University of Innsbruck Medical School, Innsbruck, Austria
-
- Johann Willeit
- Department of Neurology, University of Innsbruck Medical School, Innsbruck, Austria
-
- Friedrich Oberhollenzer
- Department of Internal Medicine, City Hospital of Bruneck, Bruneck, Italy
-
- Georg Egger
- Department of Internal Medicine, City Hospital of Bruneck, Bruneck, Italy
-
- Riccardo C. Bonadonna
- Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, Verona, Italy
-
- Michele Muggeo
- Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, Verona, Italy
抄録
<jats:p>OBJECTIVE— The present study aimed at prospectively evaluating carotid atherosclerosis and coronary heart disease (CHD) in subjects with the metabolic syndrome.</jats:p> <jats:p>RESEARCH DESIGN AND METHODS— Within a prospective population-based survey examining 888 subjects aged 40–79 years, 303 subjects were identified as fulfilling World Health Organization (WHO) criteria and 158 as fulfilling the National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP)-III criteria for diagnosing the metabolic syndrome. The 5-year change in carotid status, as assessed by echo-duplex scanning, and incident fatal and nonfatal CHD, as assessed by medical history and death certificates, were compared in subjects with the metabolic syndrome and in the rest of the sample (control subjects).</jats:p> <jats:p>RESULTS— Compared with the control subjects, subjects with the metabolic syndrome by WHO criteria had an increased 5-year incidence and progression of carotid atherosclerosis: 51 vs. 35% developed new plaques (P = 0.021) and 34 vs. 19% developed carotid stenosis >40% (P = 0.002) after adjusting for several confounders. Subjects with the metabolic syndrome by these criteria also had an increased incidence of CHD during follow-up: 8 vs. 3% in control subjects (P = 0.012). Similar results were found when the NCEP-ATPIII criteria were used.</jats:p> <jats:p>CONCLUSIONS— Subjects with the metabolic syndrome are at increased risk for both progressive carotid atherosclerosis and CHD.</jats:p>
収録刊行物
-
- Diabetes Care
-
Diabetes Care 26 (4), 1251-1257, 2003-04-01
American Diabetes Association
- Tweet
詳細情報
-
- CRID
- 1362544418690415872
-
- NII論文ID
- 30026277472
-
- ISSN
- 19355548
- 01495992
- http://id.crossref.org/issn/01495992
-
- データソース種別
-
- Crossref
- CiNii Articles